Table 3.
Patient Demographics and Clinical Characteristics
| Overall (n = 126) | Restrictive (n = 85) | Liberal (n = 41) | P | |
|---|---|---|---|---|
| Age (mean, SD) | 52 ± 12 | 52 ± 11 | 53 ± 13 | 0.779 |
| BMI (mean, SD) | 32.7 ± 5.5 | 32.5 ± 5.3 | 33.2 ± 5.9 | 0.510 |
| Race | ||||
| White | 103 (81.7) | 68 (80.0) | 35 (85.4) | |
| Hispanic | 17 (13.5) | 11 (12.9) | 6 (14.6) | |
| African American | 5 (4.0) | 5 (5.9) | 0 (0.0) | |
| Asian | 1 (0.8) | 1 (1.2) | 0 (0.0) | 0.384 |
| Prior smoking history | 33 (26.2) | 25 (29.4) | 8 (19.5) | 0.236 |
| Diabetes mellitus | 32 (25.4) | 22 (25.9) | 10 (24.4) | 0.857 |
| Mastectomy for cancer | 119 (94.4) | 81 (95.3) | 38 (92.7) | 0.681 |
| Prophylactic mastectomy | 11 (8.7) | 6 (7.1) | 5 (12.2) | 0.335 |
| Type of flap | ||||
| DIEP | 100 (79.4) | 68 (80.0) | 32 (78.0) | |
| Free TRAM | 26 (20.6) | 17 (20.0) | 9 (22.0) | 0.592 |
| Neoadjuvant chemotherapy | 80 (63.5) | 54 (63.5) | 26 (63.4) | 0.990 |
| Neoadjuvant radiation | 40 (31.7) | 32 (37.6) | 8 (19.5) | 0.040 |
| Adjuvant chemotherapy | 46 (36.5) | 29 (34.1) | 17 (41.5) | 0.422 |
| Adjuvant radiation | 16 (12.8) | 11 (13.1) | 5 (12.2) | 0.888 |
| Immediate reconstruction | 35 (27.8) | 22 (25.9) | 13 (31.7) | 0.494 |
| Bilateral reconstruction | 65 (51.6) | 41 (48.2) | 24 (58.5) | 0.278 |
| Prior abdominal surgery | 17 (13.5) | 13 (15.3) | 4 (9.6) | 0.092 |
RFR is defined as intraoperative fluid administration of ≤7 ml/kg/hour and liberal as >7 ml/kg/hour. All values are reported in n (%) unless stated otherwise.
BMI, body mass index; DIEP, deep inferior epigastric perforator; TRAM, transverse rectus abdominis muscle.